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M. Sole: I would like to comment on Dr. Floras’ presen- 
tation. Patients with cirrhosis and ascites have marked 
increases in angiotensin II and catecholamines, but such 
patients do not show increased fibrosis or hypertrophy. 
Thus, I support Dr. Floras’s suggestion that concomitant 
conditions are important in determining the effect hat cir- 
culating neurohormonal f ctors may have on the structural 
features of the heart. 
use Of peroneal nerve recordings or plasma norepinephrine 
levels. 
J. Cohn: The patient with cirrhosis has an abnormal 
response to the infusion of angiotensin. For instance, the left 
ventricle in such a patient may appear normal at rest, but the 
infusion of angiotensin markedly depresses left ventricular 
function. In many respects he p;rtient with cirrhosis behaves 
like a patient with heart failure, but this is not readily 
appreciated because the arteriovenous shunts that are char- 
acteristic of cirrhosis act to reduce the impedance on the left 
ventricle. One can demonstrate he abnormality in cardiac 
performance only by increasing impedance. In fact, in the 
absence of these shunts, patients with cirrhosis would have 
heart failure similar to that of patients with an alcoholic 
cardiomyopathy. 
M. Thames: The real issue is whether the “action” in 
heart failure is in the heart or in the peripheral circulation. 
Cirrhosis and heart failure are both characterized by neuro- 
hormonal ctivation, but the peripheral vasculature is dilated 
in cirrhosis and constricted in patients with heart failure. We 
also know that there is a very poor relationship between 
functional class and ejection fraction in patients with heart 
failure, which can be explained by changes in the peripheral 
circulation. The heart is what it is, but it is the state of the 
periphery that determines the outcome of the patient. 
A. K&z: Dr. Thames emphasized the importance of the 
peripheral circulation i determining which patients with left 
ventricular dysfunction develop symptoms and which do 
not. Is there evidence that the systemic vascular response 
also determines prognosis npatients with heart failure? 
M. Thames: I cannot answer the question. I do not think 
there are any data on this issue. 
J. Floras: Generalized sympathoneural activation is 
present in virtually all of the patients with cirrhosis and 
ascites that we have studied and is just as, or maybe ven 
more, intense as it is in congestive heart failure. The point I
emphasize is that in disorders such as cirrhosis there must be 
condition-specific countervailing forces that protect hese 
patients from the potential adverse ffects of increased 
adrenergic drive. If we can characterize the nature of the 
adaptive mechanisms, we may be able to develop new 
interventions that may be helpful in our patients with heart 
failure. 
M. Sole: Dr. Bristow, 1 believe that heterogeneity n 
sympathetic nerve traiGc to the failing heart is of pathophys- 
iologic importance. You now indicate that here are regional 
differences in receptor populations within the heart. Are 
there any data regarding the existence ofregional differences 
in the degree of receptor downregulation? Is such downreg- 
ulation onuniform? 
M. Bristow: Beta-receptor downregulation occurs 
throughout the ventricle, but there are regional differences. 
The density of beta, receptors i  lower in the apex and higher 
in the free wall. Such heterogeneity may contribute not only 
to myocardial dysfunction but also to ventricular rrhyth- 
mias. 
M. BrIstow: It is quite possible that he key factor in heart P. PO&-WiIsnn: There may be differences in receptor 
failure is not systemic adrenergic activation but increased populations ot only among different parts of the heart, but 
cardiac adrenergfc drive. Changes in systemic and cardiac also among single cells. We have shown that there are 
adrenergic activation do not necessarily occur in parallel. different proportions of receptor subtypes on individual 
With respect to heart failure, it is cardiac adrenergic drive human myocardial cells, even in cells that are adjacent to 
that is really important, and we cannot measure that by the each other. 
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